additional

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters Option to Purchase Additional Shares, and Closing of Private PlacementSenseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters Option to Purchase Additional Shares, and Closing of Private Placement

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters Option to Purchase Additional Shares, and Closing of Private Placement

May 21, 2025 17:06 ET  | Source: Senseonics Holdings, Inc. Public offering results in gross proceeds of $57.5 millionPrivate placement…

6 hours ago
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 CongressCytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress

Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress

 Two New Analyses from SEQUOIA-HCM on Effect of Aficamten Between Patientswith Mild and Moderate-to-Severe Symptoms, and Across Geographic Regions HEOR…

4 days ago
Cosmos Health Receives Additional 180-Day Compliance Period from NasdaqCosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

CHICAGO, May 06, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated…

2 weeks ago
OptimizeRx Corporation Announces Plan for Additional Board of Directors RefreshmentOptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

April 18, 2025 16:15 ET  | Source: OptimizeRx Corporation WALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the…

1 month ago
Heng Ren Partners Calls on Sinovac to Disclose the Record and Payment Dates of the Special Dividend and Distribute an Additional Dividend of $41 per ShareHeng Ren Partners Calls on Sinovac to Disclose the Record and Payment Dates of the Special Dividend and Distribute an Additional Dividend of $41 per Share

Heng Ren Partners Calls on Sinovac to Disclose the Record and Payment Dates of the Special Dividend and Distribute an Additional Dividend of $41 per Share

BOSTON, April 10, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Partners, LLC sent a letter on…

1 month ago
MSMEs Cannot Afford Additional INR 1.5 Lakhs per year as Cost of Compliance due to IMS: India SME ForumMSMEs Cannot Afford Additional INR 1.5 Lakhs per year as Cost of Compliance due to IMS: India SME Forum

MSMEs Cannot Afford Additional INR 1.5 Lakhs per year as Cost of Compliance due to IMS: India SME Forum

NEW DELHI, April 1, 2025 /PRNewswire/ -- The India SME Forum (ISF), the country's largest non-governmental organization for small and medium…

2 months ago
MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million)MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million)

MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million)

TOKYO, March 13, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”) announces that Yasuhiro…

2 months ago
IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO ConferenceIO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference

IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference

February 23, 2025 12:07 ET  | Source: IO Biotech • Findings support the development of a novel peptide vaccine targeting…

3 months ago
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares of Common StockIntelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares of Common Stock

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares of Common Stock

February 21, 2025 16:05 ET  | Source: Intelligent Bio Solutions, Inc. NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Intelligent…

3 months ago
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional SharesBeta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares

January 31, 2025 17:56 ET  | Source: Beta Bionics, Inc. IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Beta Bionics,…

4 months ago
Show more Posts